RT Journal Article
SR Electronic
T1 Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002374
DO 10.1136/jitc-2021-002374
VO 9
IS 3
A1 Bilusic, Marijo
A1 McMahon, Sheri
A1 Madan, Ravi A
A1 Karzai, Fatima
A1 Tsai, Yo-Ting
A1 Donahue, Renee N
A1 Palena, Claudia
A1 Jochems, Caroline
A1 Marté, Jennifer L
A1 Floudas, Charalampos
A1 Strauss, Julius
A1 Redman, Jason
A1 Abdul Sater, Houssein
A1 Rabizadeh, Shahrooz
A1 Soon-Shiong, Patrick
A1 Schlom, Jeffrey
A1 Gulley, James L
YR 2021
UL http://jitc.bmj.com/content/9/3/e002374.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.